feed,title,long_url,short_url
SeekingAlpha,Griffon beats top-line and bottom-line estimates; raises FY24 segment EBITDA outlook,https://seekingalpha.com/news/4102319,
SeekingAlpha,"InflaRx GAAP EPS of -€0.17 beats by €0.07, revenue of €36.03M beats by €35.89M",https://seekingalpha.com/news/4102318,
SeekingAlpha,WhiteHorse Finance NII of $0.465,https://seekingalpha.com/news/4102317,
SeekingAlpha,Orix reports FY results,https://seekingalpha.com/news/4102316,
SeekingAlpha,Brainsway beats top-line and bottom-line estimates; reaffirms FY24 outlook,https://seekingalpha.com/news/4102315,
SeekingAlpha,Earnings Summary: The New York Times tops expectations in Q1 with digital subscription revenues up 13%,https://seekingalpha.com/news/4102314,
SeekingAlpha,"Karyopharm Therapeutics GAAP EPS of -$0.32 beats by $0.03, revenue of $33.13M misses by $1.34M",https://seekingalpha.com/news/4102313,
